The cell growth inhibitory transcription factor C/EBPd is expressed in human meningiomas in association with low histological grade and proliferation index

Journal of Neuro-Oncology

Volumn 97, Issue 2, 2010, Pages 233-240

  Barresi, V ^a,c   Vitarelli, E ^a   Cerasoli, S ^b   Barresi, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b BUFALINI HOSPITAL   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

C EBP ; Inflammatory infiltrate; Ki 67; Meningioma; Prognosis; Recurrence

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INHIBITION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GRANULOCYTE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; MENINGIOMA; NEUTROPHIL; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; YOUNG ADULT;

EID: 77950457650     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-0024-0     Document Type: Article

References (29)

1. Lekstrom-Himes J, Xanthopoulos KG (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273:28545-28548
2. O'Rourke R, Yuan J, DeWille JW (1997) CCAAT/enhancer binding protein-delta is induced in growth-arrested mouse mammary epithelial cells. J Biol Chem 272:6291-6296
3. Hutt JA, O'Rourke JP, DeWille JW (2000) Stat3 activates C/ EBPd gene transcription in G0 growth arrested mouse mammary epithelial cells and in involuting mouse mammary gland. J Biol Chem 275:29123-29131
4. Gigliotti AP, Johnson PJ, Sterneck E, DeWille JW (2003) Nul-liparous CCAAT/enhancer binding proteindelta (C/EBPdelta) knockout mice exhibit mammary gland ductal hyperplasia. Exp Biol Med 228:278-285
5. Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, Hennighausen L, Huang AM, Sterneck E (2005) C/EBP d is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development 132:4675-4685
6. Sivko GS, DeWille JW (2004) CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines. J Cell Biochem 93:830-843
7. Sivko GS, Sanford DC, Dearth LD, Tang D, DeWille JW (2004) CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control. J Cell Biochem 93:844-856
8. Ikezoe T, Gery S, Yin D, O'Kelly J, Binderup L, Lemp N, Taguchi H, Koeffler HP (2005) CCAAT/enhancer-binding protein delta: a molecular target of 1, 25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells. Cancer Res 1:4762-4768
9. Sanford DC, DeWille JW (2005) C/EBP d is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells. Prostate 63:143-154
10. O'Rourke JP, Newbound GC, Hutt JA, DeWille JW (1999) C/ EBP d regulates mammary epithelial cell G0 growth arrest and apoptosis. J Biol Chem 274:16582-16589
11. Hutt J, DeWille JW (2002) Oncostatin M induces growth arrest of mammary epithelial cells via a CCAAT/enhancer binding protein delta dependent pathway. Mol Cancer Ther 1:601-610
12. Ramji DP, Foka P (2002) CCAAT/enhancer binding proteins: structure, function and regulation. Biochem J 365:561-575
13. Sundfeldt K, Ivarsson K, Carlsson M, Enerbäck S, Janson PO, Brännström M, Hedin L (1999) The expression of CCAAT/ enhancer binding protein (C/EBP) in the human ovary in vivo specific increase in C/EBPbeta during epithelial tumour progression. Br J Cancer 79:1240-1248
14. Cardinaux JR, Allaman I, Magistretti PJ (2000) Pro-inflammatory cytokines induce the transcription factors C/EBPb and C/EBPd in astrocytes. Glia 29:91-97
15. Homma J, Yamanaka R, Yajima N, Tsuchiya N, Genkai N, Sano M, Tanaka R (2006) Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Oncol Rep 15:595-601
16. Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumors of the central nervous system. IARCC Press, Lyon, pp 164-172
17. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39
18. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262-2269
19. Kamitani H, Masuzwa H, Kanazawa I, Kubo T (2001) Recurrence of convexity meningiomas: tumour cells in the arachnoid membrane. Surg Neurol 56:228-235
20. Barresi V, Cerasoli S, Paioli G, Vitarelli E, Giuffrè G, Guiducci G, Tuccari G, Barresi G (2006) Caveolin-1 in meningiomas: expression and clinico-pathological correlations. Acta Neuropa-thol 112:617-626
21. Barresi V, Cerasoli S, Vitarelli E, Tuccari G (2007) Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 114:147-156
22. Barresi V, Vitarelli E, Cerasoli S (2009) Semaphorin3A immu-nohistochemical expression in human meningiomas: correlation with the microvessel density. Virchows Arch 454:563-571
23. Billiard J, Humayahara Y, Wirens K, Centrella M, McCarthy TL, Rotwein P (2001) Regulated nuclear-cytoplasmic localization of CCAAT/enhancer binding protein d in osteoblasts. J Biol Chem 276:15354-15361
24. Gery S, Tanosaki S, Hofmann WK, Koppel A, Koeffler HP (2005) C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation. Oncogene 24:1589-1597
25. Bovle-Walsh E, Hashim IA, Speirs V, Fraser WD, White MC (1994) Interleukin-6 (IL-6) production and cell growth of cultured human meningiomas: interactions with interleukin-1 beta (IL-1 beta) and interleukin-4 (IL-4) in vitro. Neurosci Lett 170:129-132 (Pubitemid 24117304)
26. Todo T, Adams EF, Rafferty B, Fahlbusch R, Dingermann T, Werner H (1994) Secretion of interleukin-6 by human meningi-oma cells: possible autocrine inhibitory regulation of neoplastic cell growth. J Neurosurg 81:394-401 (Pubitemid 24267647)
27. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J (1992) Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31:2-12
28. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) "Malignancy" in meningiomas: a clinico-pathological study of 116 patients, with grading implications. Cancer 85: 2046-2056 (Pubitemid 29202781)
29. Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R (1998) Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. J Neurosurg 88:541-548 (Pubitemid 28114729)